Is transcranial magnetic stimulation effective in treatmentresistant combat related posttraumatic stress disorder?

Neurosciences

Volumn 19, Issue 1, 2014, Pages 29-32

  Oznur, Taner ^a   Akarsu, Süleyman ^b   Celik, Cemil ^a   Bolu, Abdullah ^c   Ozdemir, Barbaros ^a   Akcay, Bülent D ^d   Ozselek, Süleyman ^b   Bozkurt, Ali ^a   Ozmenler, Kamil N ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Department of Psychiatry Aksaz Military Hospital   (Turkey)

^c Department of Psychiatry Eskisehir Military Hospital ^*  (Turkey)

^d Konya Military Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; HUMAN; IMPACT OF EVENTS SCALE; IMPACT OF EVENTS SCALE AVOIDANCE SCORE; IMPACT OF EVENTS SCALE HYPERAROUSAL SCORE; IMPACT OF EVENTS SCALE INTRUSION SCORE; MAJOR DEPRESSION; MALE; POSTTRAUMATIC STRESS DISORDER; SCORING SYSTEM; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION; ELECTROENCEPHALOGRAPHY; METHODOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; PSYCHOLOGICAL RATING SCALE; SEVERITY OF ILLNESS INDEX;

ADULT; ELECTROENCEPHALOGRAPHY; HUMANS; MALE; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84901718130     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Shaul U, Ben-Shachar D, Karry R, Klein E. Modulation of frequency and duration of repetitive magnetic stimulation affects catecholamine levels and tyrosine hydroxylase activity in human neuroblastoma cells: implication for the antidepressant effect of rTMS. Int J Neuropsychopharmacol 2003; 6: 233-241.
2. O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62: 1208-1216.
3. Avery DH, Holtzheimer PE 3rd, Fawaz W, Russo J, Neumaier J, Dunner DL, et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry 2006; 59: 187-194.
4. Avery DH, Isenberg KE, Sampson SM, Janicak PG, Lisanby SH, Maixner DF, et al. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry 2008; 69: 441-451.
5. Lisanby SH, Husain MM, Rosenquist PB, Maixner D, Gutierrez R, Krystal A, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 2009; 34: 522-534.
6. George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a shamcontrolled randomized trial. Arch Gen Psychiatry 2010; 67: 507-516.
7. Watts BV, Landon B, Groft A, Young-Xu Y. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul 2012; 5: 38-43.
8. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version. Washington (DC): American Psychiatric Press; 1997.
9. Weiss DS, Marmar, CR. The Impact of Event Scale-Revised. In: Wilson JP, Keane TM, editors. Assessing psychological trauma and PTSD: A handbook for practitioners. New York (NY): Guilford Press; 1997. p. 399-411.
10. Beck AT, Rial WY, Rickels K. Short form of depression inventory: cross-validation. Psychological Reports 1974; 34: 1184-1186.
11. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56: 893-897.
12. Boggio PS, Rocha M, Oliveira MO, Fecteau S, Cohen RB, Campanhã C, et al. Noninvasive brain stimulation with highfrequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry 2010; 71: 992-999.
13. Galletly C, Clark CR, McFarlane AC, Weber DL. Working memory in posttraumatic stress disorder--an event-related potential study. J Trauma Stress 2001; 14: 295-309.
14. Nejad AG, Farahati H. Dissociative disorders and dissociative symptoms among veterans of the Iraq-Iran war suffering from chronic posttraumatic disorder. Neurosciences (Riyadh) 2007; 12: 318-321.
15. Mehdiyev ES, Celik C, Ozdemir B. Comorbidity of posttraumatic stress disorder and alcohol use disorders in a sample of Karabagh war veterans. Gulhane Medical Journal 2009; 51: 212-215.
16. Ikin JF, Sim MR, McKenzie DP, Horsley KW, Wilson EJ, Moore MR, et al. Anxiety, post-traumatic stress disorder and depression in Korean War veterans 50 years after the war. Br J Psychiatry 2007; 190: 475-483.
17. Xu JJ, Chan MJ, Yang YC. Fluoxetine as a treatment for posttraumatic stress disorder. Neurosciences (Riyadh) 2011; 16: 257-262.
18. Nardo D, Högberg G, Looi JC, Larsson S, Hällström T, Pagani M. Gray matter density in limbic and paralimbic cortices is associated with trauma load and EMDR outcome in PTSD patients. J Psychiatr Res 2010; 44: 477-485.
19. Novakovic V, Sher L, Lapidus KA, Mindes J, Golier J, Yehuda R. Brain stimulation in posttraumatic stress disorder. Eur J Psychotraumatol 2011; 2: 5609.
20. McCann UD, Kimbrell TA, Morgan CM, Anderson T, Geraci M, Benson BE, et al. Repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Arch Gen Psychiatry 1998; 55: 276-279.
21. Berger U, Korngreen A, Bar-Gad I, Friedman A, Wolfus S, Yeshurun Y, et al. Magnetic stimulation intensity modulates motor inhibition. Neurosci Lett 2011; 504: 93-97.
22. Nitschke JB, Heller W. Distinguishing neural substrates of heterogeneity among anxiety disorders. Int Rev Neurobiol 2005; 67: 1-42.
23. Schutter DJ, van Honk J, d'Alfonso AA, Postma A, de Haan EH. Effects of slow rTMS at the right dorsolateral prefrontal cortex on EEG asymmetry and mood. Neuroreport 2001; 12: 445-447.
24. d'Alfonso AA, van Honk J, Hermans E, Postma A, de Haan EH. Laterality effects in selective attention to threat after repetitive transcranial magnetic stimulation at the prefrontal cortex in female subjects. Neurosci Lett 2000; 280: 195-198.
25. Osuch EA, Benson BE, Luckenbaugh DA, Geraci M, Post RM, McCann U. Repetitive TMS combined with exposure therapy for PTSD: A preliminary study. J Anxiety Disord 2009; 23: 54-59.
26. Cohen H, Kaplan Z, Kotler M, Kouperman I, Moisa R, Grisaru N. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2004; 161: 515-524.
27. Vennewald N, Diemer J, Zwanzger P. Repetitive Transcranial Magnetic Stimulation (rTMS) for Anxiety Disorders-A Possible Therapeutic Option? Fortschr Neurol Psychiatr 2013; 81: 550-560.